This week The New P&L speaks to Dr Doina Ionescu, Managing Director for the UK & Ireland for global pharmaceutical and healthcare giant, Merck.

Since joining Merck as a research scientist in 1998, Doina has held a diverse range of roles within the company including in Corporate Business Development, Corporate Mergers & Acquisitions and Commercial Operations, and was appointed to Managing Director in 2020.

In June this year, Doina was also elected to the Board of Directors for the Association of British Pharmaceutical Industry (ABPI). Doina represents Merck on the European Medicines Group, contributing towards the development of its policy positions and advocacy efforts. We discuss:

· How Doina defines leadership and how she delivers her definition practically in the business

· How to balance free thinking that leads to innovation but ensuring while still ensuring it is in line with a company’s strategic vision

· How pandemic turned approaches to innovation and R&D on their heads

· Doina’s view on the most critical leadership competency for leaders of the future

· What the convergence of healthcare and big tech might mean for the future of the industry

· What Doina believe leaders should do in their first 100 days in office

· How to improve knowledge management and dissemination across an organisation

· Merck’s ‘Mobilse for Growth’ strategy

· Doina’s very personal journey that led to a career in healthcare

If you’d like to learn more about what Doina and her team do, go to: https://www.merckgroup.com/

https://twitter.com/merckgroup

https://www.linkedin.com/company/merck-healthcare-uk/

If you’d like to join The New P&L movement for more principled leadership and more purpose-led business and keep up to date with all our latest news, go to www.principlesandleadership.com and subscribe.

Twitter: @TheNewPandL

Insta: @principlesandleadership

LinkedIn page: Principlesandleadership